@rgentatx.com
Developing RNA-targeting medicines to treat previously incurable diseases Learn More Rgenta Therapeutics is developing a pipeline of oral, small-molecule RN .
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Rgenta Therapeutics is a pioneering biotechnology start-up dedicated to developing groundbreaking RNA-targeting medicines to address diseases that were previously considered incurable. With an initial focus on oncology and neurological disorders, Rgenta Therapeutics is building a robust pipeline of oral, small-molecule drugs that target RNA. Utilizing their innovative RNA-Targeting Discovery Platform, the team at Rgenta Therapeutics is revolutionizing precision medicine.
By specifically targeting RNA, they aim to overcome the limitations of traditional drug development and unlock new treatment options for historically undruggable disease targets. The recent successful completion of a $52 million Series A financing round highlights the confidence and support from investors, including AZ-CICC Healthcare Investment Fund, Korean Investment Partners, and Delos Capital. At Rgenta Therapeutics, they are driven by a vision to improve patient outcomes through precision medicine.
If you share their passion for making a meaningful impact, consider joining their dynamic team. With their office located in Woburn, Massachusetts, Rgenta Therapeutics is actively seeking talented individuals to contribute to their exciting journey of medical innovation. Reach out to them to explore career opportunities.
Contact: 300 TradeCenter Suite 6600 Woburn, MA 01801 info@rgentatx. com
Company Type
Privately Held
Company Size
11-50
Year Founded
2018
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories